Literature DB >> 33919355

RGB-Marking to Identify Patterns of Selection and Neutral Evolution in Human Osteosarcoma Models.

Stefano Gambera1, Ana Patiño-Garcia2, Arantzazu Alfranca1,3, Javier Garcia-Castro1.   

Abstract

Osteosarcoma (OS) is a highly aggressive tumor characterized by malignant cells producing pathologic bone; the disease presents a natural tendency to metastasize. Genetic studies indicate that the OS genome is extremely complex, presenting signs of macro-evolution, and linear and branched patterns of clonal development. However, those studies were based on the phylogenetic reconstruction of next-generation sequencing (NGS) data, which present important limitations. Thus, testing clonal evolution in experimental models could be useful for validating this hypothesis. In the present study, lentiviral LeGO-vectors were employed to generate colorimetric red, green, blue (RGB)-marking in murine, canine, and human OS. With this strategy, we studied tumor heterogeneity and the clonal dynamics occurring in vivo in immunodeficient NOD.Cg-Prkdcscid-Il2rgtm1Wjl/SzJ (NSG) mice. Based on colorimetric label, tumor clonal composition was analyzed by confocal microscopy, flow cytometry, and different types of supervised and unsupervised clonal analyses. With this approach, we observed a consistent reduction in the clonal composition of RGB-marked tumors and identified evident clonal selection at the first passage in immunodeficient mice. Furthermore, we also demonstrated that OS could follow a neutral model of growth, where the disease is defined by the coexistence of different tumor sub-clones. Our study demonstrates the importance of rigorous testing of the selective forces in commonly used experimental models.

Entities:  

Keywords:  RGB-marking; cancer models; clonal evolution; osteosarcoma

Year:  2021        PMID: 33919355     DOI: 10.3390/cancers13092003

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  37 in total

1.  RGB marking with lentiviral vectors for multicolor clonal cell tracking.

Authors:  Kristoffer Weber; Michael Thomaschewski; Daniel Benten; Boris Fehse
Journal:  Nat Protoc       Date:  2012-04-05       Impact factor: 13.491

2.  Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties.

Authors:  S B Rodan; Y Imai; M A Thiede; G Wesolowski; D Thompson; Z Bar-Shavit; S Shull; K Mann; G A Rodan
Journal:  Cancer Res       Date:  1987-09-15       Impact factor: 12.701

3.  Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors: 
Journal:  Ann Oncol       Date:  2014-09       Impact factor: 32.976

4.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

5.  The landscape of genomic alterations across childhood cancers.

Authors:  Susanne N Gröbner; Barbara C Worst; Joachim Weischenfeldt; Ivo Buchhalter; Kortine Kleinheinz; Vasilisa A Rudneva; Pascal D Johann; Gnana Prakash Balasubramanian; Maia Segura-Wang; Sebastian Brabetz; Sebastian Bender; Barbara Hutter; Dominik Sturm; Elke Pfaff; Daniel Hübschmann; Gideon Zipprich; Michael Heinold; Jürgen Eils; Christian Lawerenz; Serap Erkek; Sander Lambo; Sebastian Waszak; Claudia Blattmann; Arndt Borkhardt; Michaela Kuhlen; Angelika Eggert; Simone Fulda; Manfred Gessler; Jenny Wegert; Roland Kappler; Daniel Baumhoer; Stefan Burdach; Renate Kirschner-Schwabe; Udo Kontny; Andreas E Kulozik; Dietmar Lohmann; Simone Hettmer; Cornelia Eckert; Stefan Bielack; Michaela Nathrath; Charlotte Niemeyer; Günther H Richter; Johannes Schulte; Reiner Siebert; Frank Westermann; Jan J Molenaar; Gilles Vassal; Hendrik Witt; Birgit Burkhardt; Christian P Kratz; Olaf Witt; Cornelis M van Tilburg; Christof M Kramm; Gudrun Fleischhack; Uta Dirksen; Stefan Rutkowski; Michael Frühwald; Katja von Hoff; Stephan Wolf; Thomas Klingebiel; Ewa Koscielniak; Pablo Landgraf; Jan Koster; Adam C Resnick; Jinghui Zhang; Yanling Liu; Xin Zhou; Angela J Waanders; Danny A Zwijnenburg; Pichai Raman; Benedikt Brors; Ursula D Weber; Paul A Northcott; Kristian W Pajtler; Marcel Kool; Rosario M Piro; Jan O Korbel; Matthias Schlesner; Roland Eils; David T W Jones; Peter Lichter; Lukas Chavez; Marc Zapatka; Stefan M Pfister
Journal:  Nature       Date:  2018-02-28       Impact factor: 49.962

6.  Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases.

Authors:  Di Wang; Xiaohui Niu; Zhijie Wang; Cheng-Li Song; Zhen Huang; Ke-Neng Chen; Jianchun Duan; Hua Bai; Jiachen Xu; Jun Zhao; Yu Wang; Minglei Zhuo; X Sunney Xie; Xiaozheng Kang; Yanhua Tian; Liangliang Cai; Jie-Fei Han; Tongtong An; Yu Sun; Shugeng Gao; Jun Zhao; Jianming Ying; Luhua Wang; Jie He; Jie Wang
Journal:  Cancer Res       Date:  2018-11-02       Impact factor: 12.701

7.  Immuno-genomic landscape of osteosarcoma.

Authors:  Chia-Chin Wu; Hannah C Beird; J Andrew Livingston; Shailesh Advani; Akash Mitra; Shaolong Cao; Alexandre Reuben; Davis Ingram; Wei-Lien Wang; Zhenlin Ju; Cheuk Hong Leung; Heather Lin; Youyun Zheng; Jason Roszik; Wenyi Wang; Shreyaskumar Patel; Robert S Benjamin; Neeta Somaiah; Anthony P Conley; Gordon B Mills; Patrick Hwu; Richard Gorlick; Alexander Lazar; Najat C Daw; Valerae Lewis; P Andrew Futreal
Journal:  Nat Commun       Date:  2020-02-21       Impact factor: 14.919

8.  The evolutionary history of 2,658 cancers.

Authors:  Moritz Gerstung; Clemency Jolly; Ignaty Leshchiner; Stefan C Dentro; Santiago Gonzalez; Daniel Rosebrock; Thomas J Mitchell; Yulia Rubanova; Pavana Anur; Kaixian Yu; Maxime Tarabichi; Amit Deshwar; Jeff Wintersinger; Kortine Kleinheinz; Ignacio Vázquez-García; Kerstin Haase; Lara Jerman; Subhajit Sengupta; Geoff Macintyre; Salem Malikic; Nilgun Donmez; Dimitri G Livitz; Marek Cmero; Jonas Demeulemeester; Steven Schumacher; Yu Fan; Xiaotong Yao; Juhee Lee; Matthias Schlesner; Paul C Boutros; David D Bowtell; Hongtu Zhu; Gad Getz; Marcin Imielinski; Rameen Beroukhim; S Cenk Sahinalp; Yuan Ji; Martin Peifer; Florian Markowetz; Ville Mustonen; Ke Yuan; Wenyi Wang; Quaid D Morris; Paul T Spellman; David C Wedge; Peter Van Loo
Journal:  Nature       Date:  2020-02-06       Impact factor: 49.962

9.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

10.  Patient-derived xenografts undergo mouse-specific tumor evolution.

Authors:  Uri Ben-David; Gavin Ha; Yuen-Yi Tseng; Noah F Greenwald; Coyin Oh; Juliann Shih; James M McFarland; Bang Wong; Jesse S Boehm; Rameen Beroukhim; Todd R Golub
Journal:  Nat Genet       Date:  2017-10-09       Impact factor: 38.330

View more
  2 in total

Review 1.  Bone tumors effective therapy through functionalized hydrogels: current developments and future expectations.

Authors:  Ruyi Shao; Yeben Wang; Laifeng Li; Yongqiang Dong; Jiayi Zhao; Wenqing Liang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 2.  Recent Advances in the Treatment of Bone Metastases and Primary Bone Tumors: An Up-to-Date Review.

Authors:  Adrian Emilian Bădilă; Dragoș Mihai Rădulescu; Adelina-Gabriela Niculescu; Alexandru Mihai Grumezescu; Marius Rădulescu; Adrian Radu Rădulescu
Journal:  Cancers (Basel)       Date:  2021-08-23       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.